NASDAQ$ACHC

Acadia Healthcare Company Inc. · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

Acadia Healthcare reported strong financial and operating performance due to increased demand and focus on efficiencies.

Acadia Healthcare reported revenue of $582.2 million for the second quarter of 2021, a significant increase from $491.5 million in the same period last year. Net income attributable to Acadia stockholders was $44.5 million, or $0.49 per diluted share, compared to $41.1 million, or $0.46 per diluted share, for the second quarter of 2020. The company is increasing financial guidance for 2021.

  • Revenue increased to $582.2 million compared to $491.5 million for the second quarter of 2020.
  • Adjusted EBITDA increased 25.2% to $141.3 million.
  • Net income attributable to Acadia stockholders was $44.5 million, or $0.49 per diluted share.
  • Acadia added 86 beds to its operations, including 72 from the opening of a replacement facility for Belmont Behavioral Hospital.

Headline financials

Total Revenue

$582M

Previous: $750M-22.4%
EPS (adj)

$0.71

Previous: $0.54+31.5%
US Same-Facility Rev. Growth

18.0%

Previous: -3.4%+629.4%
US Same-Facility Patient Days Growth

9.8%

Previous: -0.7%+1500.0%
US Same-Facility Rev/Day Growth

7.5%

Previous: -2.7%+377.8%
Capital Expenditures

-$113M

Previous: -$132M+14.5%
Free Cash Flow

-$68.4M

Previous: -$91M+24.8%
Net Income

$44.5M

Previous: $41.1M+8.4%
Operating Income

-$159M

Previous: -$227M+29.7%
Gross Profit

$18.1M

Previous: $18.1M+0.0%
Cash & Equivalents

$186M

Previous: $212M-12.5%
Total Assets

$4.56B

Previous: $6.83B-33.2%
Stock-Based Comp

$9.03M

Previous: $5.81M+55.5%

Revenue & EPS history

Acadia Healthcare · Revenue · Quarterly

$582M

Q2 2021-22.4%vs Q2 2020
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Forward guidance

Acadia increased the Company’s financial guidance for 2021 to reflect the strong operating and financial performance for the first six months of the year and its expectations for the remainder of the year, as follows:

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

+1.5%

Avg return

Earnings day

+1.4%

Avg return

5 days after

+2.5%

Avg return

30 days after

60%

38 / 63 earnings

Positive

+23.1%

Q3 2020

Best reaction

-26.9%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.5%+0.3%-16.0%
Q4 2025+21.4%+36.5%+33.4%
Q3 2025-5.5%-10.2%-25.2%
Q1 2025+4.2%+1.2%-14.4%
Q4 2024-25.5%-26.3%-25.2%
Q3 2024-17.3%-18.0%-21.3%
Q2 2024+10.0%+5.4%+21.6%
Q1 2024-9.8%-8.3%-6.8%
Q4 2023-2.4%-1.8%-7.3%
Q3 2023-1.7%+1.1%+0.5%
Q2 2023+7.8%+6.5%+2.9%
Q1 2023-1.3%-4.4%-6.0%
Q4 2022-9.6%-7.3%-12.1%
Q3 2022-3.4%-5.5%+7.2%
Q2 2022+3.6%+3.9%+4.8%
Q1 2022+8.0%+5.4%+6.4%
Q4 2021+6.5%+9.3%+15.3%
Q3 2021+10.5%+11.8%+3.0%
Q2 2021+3.1%+1.3%+8.0%
Q1 2021-1.1%+1.1%+4.4%
Q4 2020+1.5%+2.5%+6.0%
Q3 2020+23.1%+28.7%+49.1%
Q2 2020+2.3%+2.7%-0.1%
Q1 2020+16.7%+18.2%+26.7%
Q4 2019-5.9%+6.0%+100.5%
Q3 2019-3.5%-2.0%+2.5%
Q2 2019-3.3%-12.0%-19.6%
Q1 2019+0.0%+3.2%+1.4%
Q4 2018+15.9%+11.7%+11.7%
Q3 2018-12.8%-5.0%-26.0%
Q2 2018-10.6%-7.4%-8.0%
Q1 2018+9.0%+11.7%+13.0%
Q4 2017+8.5%+6.8%+8.4%
Q3 2017-26.9%-25.6%-30.7%
Q2 2017+7.6%+5.7%-7.5%
Q1 2017-3.1%+0.0%-2.4%
Q4 2016+5.4%+4.9%-1.7%
Q3 2016+3.1%+3.8%+5.9%
Q2 2016-1.3%-0.8%-4.8%
Q1 2016-0.8%
Q4 2015+5.7%
Q3 2015+9.4%
Q2 2015+3.4%
Q1 2015-2.9%
Q4 2014-0.4%
Q3 2014+11.2%
Q2 2014-2.1%
Q1 2014+0.4%
Q4 2013-2.8%
Q3 2013+9.0%
Q2 2013+8.2%
Q1 2013+2.9%
Q4 2009+2.3%
Q4 2012+0.1%
Q3 2012+2.3%
Q2 2012+7.5%
Q2 2011+4.4%
Q1 2012+6.5%
Q1 2011-1.0%
Q4 2011+3.3%
Q4 2010+0.1%
Q3 2011+0.1%
Q3 2010+0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro